共 57 条
[1]
The updated incidences and mortalities of major cancers in China, 2011
[J].
Chinese Journal of Cancer,
2015, 34 (11)
:502-507
Wanqing Chen
;
Rongshou Zheng
;
Hongmei Zeng
;
Siwei Zhang
.
[2]
TCGA divides gastric cancer into four molecular subtypes:implications for individualized therapeutics[J] Wei Zhang; Chinese Journal of Cancer 2014, 10
[3]
Immune checkpoint inhibitors in clinical trials
[J].
Chinese Journal of Cancer,
2014, 33 (09)
:434-444
Elad Sharon
;
Howard Streicher
;
Priscila Goncalves
;
Helen XChen
.
[4]
Increasing the frequency of CIK cells adoptive immunotherapy may decrease risk of death in gastric cancer patients[J] Jing-Ting Jiang; Chang-Ping Wu; Lu-Jun Chen; Xiao Zheng; Department of Tumor Biological Treatment; Third Affiliated Hospital of Soochow University; Changzhou 213003; Jiangsu Province; China Yi-Bei Zhu; Jing Sun; Xue-Guang Zhang; Key Laboratory of Stem Cell of Jiangsu Province; Institute of Biotechnology; Key Laboratory of Clinical Immunology of Jiangsu Province; Soochow Universit
[5]
Programmed cell death protein 1 expression is an independent prognostic factor in gastric cancer after curative resection.[J] Eto Shohei;Yoshikawa Kozo;Nishi Masaaki;Higashijima Jun;Tokunaga Takuya;Nakao Toshihiro;Kashihara Hideya;Takasu Chie;Iwata Takashi;Shimada Mitsuo Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2016,
[6]
Prognostic implications of immunosuppressive protein expression in tumors as well as immune cell infiltration within the tumor microenvironment in gastric cancer.[J] Kim Jin Won;Nam Kyung Han;Ahn Sang-Hoon;Park Do Joong;Kim Hyung-Ho;Kim Se Hyun;Chang Hyun;Lee Jeong-Ok;Kim Yu Jung;Lee Hye Seung;Kim Jee Hyun;Bang Soo-Mee;Lee Jong Seok;Lee Keun-Wook Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2016,
[7]
S-1 plus cisplatin versus fluorouracil plus cisplatin in advanced gastric or gastro-esophageal junction adenocarcinoma patients: a pilot study.[J] Li Yu Hong;Qiu Miao Zhen;Xu Jian Ming;Sun Guo Ping;Lu Hui Shan;Liu Yun Peng;Zhong Mei Zuo;Zhang He Long;Yu Shi Ying;Li Wei;Hu Xiao Hua;Wang Jie Jun;Cheng Ying;Zhou Jun Tian;Guo Zeng Qing;Guan Zhon Gzhen;Xu Rui Hua Oncotarget 2015,
[8]
Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?[J] L. Apetoh;S. Ladoire;G. Coukos;F. Ghiringhelli Annals of Oncology 2015,
[9]
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.[J] Larkin James;Hodi F Stephen;Wolchok Jedd D The New England journal of medicine 2015,
[10]
EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment[J] Alina Nicolae;Stefania Pittaluga;Shahed Abdullah;Seth M. Steinberg;Thu Anh Pham;Theresa Davies-Hill;Liqiang Xi;Mark Raffeld;Elaine S. Jaffe Blood 2015,